Bank of New York Mellon Corp - HI-TECH PHARMACAL INC ownership

HI-TECH PHARMACAL INC's ticker is HITK and the CUSIP is 42840B101. A total of 102 filers reported holding HI-TECH PHARMACAL INC in Q4 2013. The put-call ratio across all filers is 146.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of HI-TECH PHARMACAL INC
ValueSharesWeighting
Q1 2014$5,359,000
-2.0%
123,688
-1.8%
0.00%
-50.0%
Q4 2013$5,467,000
-48.6%
125,979
-48.9%
0.00%0.0%
Q3 2013$10,636,000
+171.5%
246,512
+109.0%
0.00%
+100.0%
Q2 2013$3,917,000117,9450.00%
Other shareholders
HI-TECH PHARMACAL INC shareholders Q4 2013
NameSharesValueWeighting ↓
GLAZER CAPITAL, LLC 219,105$9,507,0004.06%
Euclidean Technologies Management, LLC 91,079$3,952,0003.61%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 411,254$17,844,0002.93%
GABELLI & Co INVESTMENT ADVISERS, INC. 137,361$5,960,0002.15%
TOURADJI CAPITAL MANAGEMENT, LP 6,000$260,0000.98%
Cowen Prime Services LLC 14,340$622,0000.24%
AQR Capital Management 1,273,011$55,236,0000.16%
CONTINENTAL ADVISORS LLC 12,900$560,0000.12%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 167,612$7,273,0000.12%
PRELUDE CAPITAL MANAGEMENT, LLC 15,000$651,0000.11%
View complete list of HI-TECH PHARMACAL INC shareholders